Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma

Published:2020-09 Issue: Volume:18 Page:83-99
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Federico Aniello,Steinfass Tamara,Larribère Lionel,Novak Daniel,Morís Francisco,Núñez Luz-Elena,Umansky Viktor,Utikal Jochen

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference78 articles.

1. Epidemiology of skin cancer;Leiter;Adv. Exp. Med. Biol.,2014

2. The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031;Whiteman;J. Invest. Dermatol.,2016

3. Combination therapy for metastatic melanoma: a pharmacist’s role, drug interactions & complementary alternative therapies;Gazzé;Melanoma Manag.,2018

4. Chemotherapy Resistance Mechanisms in Advanced Skin Cancer;Kalal;Oncol. Rev.,2017

5. The role of BRAF V600 mutation in melanoma;Ascierto;J. Transl. Med.,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes;2024-01-16

2. The functions of SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) in biological process and disease;Epigenetics & Chromatin;2023-12-07

3. Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling;Biomedicine & Pharmacotherapy;2023-06

4. ΔNp63α in cancer: importance and therapeutic opportunities;Trends in Cell Biology;2023-04

5. Secretogranin II influences the assembly and function of MHC class I in melanoma;Experimental Hematology & Oncology;2023-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3